Cured has a total of 16 patents globally, out of which 1 has been granted. Of these 16 patents, more than 43% patents are active. Japan is where Cured has filed the maximum number of patents, followed by USA and Europe. Parallelly, Japan seems to be the main focused R&D centre and also USA is the origin country of Cured.
Cured was founded in 2018. Cured develops specialized digital marketing and CRM software for the healthcare industry.
Do read about some of the most popular patents of Cured which have been covered by us in this article and also you can find Cured patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Cured patent portfolio.
How many patents does Cured have?
Cured has a total of 16 patents globally. These patents belong to 5 unique patent families. Out of 16 patents, 7 patents are active.
How Many Patents Did Cured File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Cured Applications Filed | Cured Patents Granted |
| 2022 | 2 | – |
| 2021 | 2 | – |
| 2019 | 6 | – |
| 2017 | 1 | 1 |
| 2016 | 1 | – |
| 2015 | 1 | – |
| 2014 | 3 | – |
How many Cured patents are Alive/Dead?
Worldwide Patents
How Many Patents Did Cured File in Different Countries?
Countries in which Cured Filed Patents
| Country | Patent |
| Japan | 5 |
| United States Of America | 3 |
| Europe | 2 |
| Taiwan | 1 |
| Canada | 1 |
| Hong Kong (S.A.R.) | 1 |
Where are Research Centers of Cured Patents Located?
The Research Centers of Cured Patents is Japan.
List of Cured patents
| Cured Patents | Title |
| US20220002389A1 | Anti-Hiv Antibody And Method For Producing Same |
| EP3875480A4 | Anti-Hiv Antibody And Method For Producing Same |
| WO2023171009A1 | Humanized Antibody That Bonds To Eva1 Protein Or Functional Fragment Thereof, Antibody-Drug Conjugate And Chimeric Antigen Receptor |
| JP2023002806A | Anti-Hiv Antibody And Its Production Method |
| HK40052483A | Anti-Hiv Antibody And Method For Producing Same |
| TW202029981A | Anti-Hiv Antibody And Method For Producing Same |
| CA3118073A1 | Anti-Hiv Antibody And Method For Producing Same |
| US9765151B2 | Method For Producing Monoclonal Iga Antibody |
| US20180009906A1 | Method For Producing Monoclonal Iga Antibody |
| EP2995679A4 | Method For Producing Monoclonal Iga Antibody |
| WO2022145443A1 | Pharmaceutical Composition For Treating Chronic Kidney Disease |
| JPWO2020090747A1 | Anti-Hiv Antibody And Method For Producing The Same |
| WO2020090747A1 | Anti-Hiv Antibody And Method For Producing Same |
| JP2016183153A5 | Method For Producing Monoclonal Iga Antibody |
| JPWO2014142084A1 | Method For Producing Monoclonal Iga Antibody |
| JP2017001987A | Polypeptide |
What are Cured key innovation segments?
What Technologies are Covered by Cured?
The chart below distributes patents filed by Cured in different countries on the basis of the technology protected in patents. It also represents the markets where Cured thinks it’s important to protect particular technology inventions.
R&D Focus: How has Cured search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Cured?